After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

COPD, a progressive condition affecting millions globally, has historically relied on inhaled therapies. However, biologics like Dupixent (dupilumab) have paved the way for a new treatment ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

It has been found in a recent study published in Heliyon that individuals who are genetically predisposed to having ...

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

Hospital-at-home initiatives use innovative technologies and sensors to deliver continuous care, improving patient quality of ...